Alzheimer?s Disease Neuroimaging Initiative
The Alzheimer's Disease Neuroimaging Initiative (ADNI) is a public-private research partnership that aims to develop treatments for Alzheimer's disease (AD) through neuroimaging and biomarker technologies. By collecting and analyzing MRI, PET, and other brain imaging data from AD patients, ADNI is able to track changes in brain structure and chemistry, identify markers for disease progression, and develop treatments that can better help people with AD. ADNI is an important tool for developing and evaluating new treatments for Alzheimer’s, and can help provide valuable insight into the pathology of the disease.
← Journal of Alzheimer's Research and Therapy